GCAN Company Profile and Key Details

Q: Who are the executives of GCAN?

Mr. Aitan ZacharinChairman, Pres, Chief Executive Officer, Acting Chief Financial Officer & Treasurer

PNK : GCAN

Greater Cannabis

$0.00

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

The Greater Cannabis Company, Inc. (GCAN) stock surged +5.71%, trading at $0.37 on OTC, up from the previous close of $0.35. The stock opened at $0.38, fluctuating between $0.35 and $0.38 in the recent session.

Stock Snapshot

0.35

Prev. Close

367.92K

Market Cap

0.35

Day Low

-1947.37

P/E Ratio

-0.00019

EPS (TTM)

Cash Flow per Share

0.38

Open

994.38K

Number of Shares

0.3795

Day High

92.59%

Free Float in %

Book Value

200

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	0.38	0.38	0.37	0.37	909
Sep 08, 2026	0.35	0.35	0.35	0.35	10.88K
Aug 31, 2026	0.40	0.40	0.23	0.23	7.91K
Aug 27, 2026	0.32	0.33	0.30	0.30	16.12K
Aug 26, 2026	0.25	0.25	0.25	0.25	5.12K
Aug 24, 2026	0.23	0.23	0.15	0.20	5.3K
Aug 18, 2026	0.25	0.25	0.25	0.25	9K
Aug 17, 2026	0.33	0.33	0.33	0.33	10.59K
Aug 12, 2026	0.23	0.23	0.23	0.23	1.89K
Aug 10, 2026	0.23	0.28	0.23	0.28	2.04K
Aug 06, 2026	0.38	0.38	0.38	0.38	116
Aug 05, 2026	0.28	0.28	0.28	0.28	400
Aug 03, 2026	0.28	0.28	0.28	0.28	2.81K
Jul 31, 2026	0.31	0.35	0.31	0.33	8.65K
Jul 30, 2026	0.25	0.25	0.22	0.22	3.07K
Jul 29, 2026	0.25	0.25	0.25	0.25	3.57K
Jul 27, 2026	0.25	0.25	0.25	0.25	1.02K
Jul 24, 2026	0.27	0.27	0.27	0.27	5K
Jul 22, 2026	0.31	0.31	0.31	0.31	400
Jul 21, 2026	0.31	0.34	0.31	0.34	409

Contact Details

Miami, FL 33131

United States

https://www.gcanrx.com 443 738 4051

About Company

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.

Stock Peers

ODTC

Odonate Therapeutics, Inc.$2,849.50 LFLY

Leafly Holdings, Inc.$37.00 CLCGY

0.99+3.05%

Clicks Group Limited$33.50 KYKOF

-0.2-1.16%

Kyowa Kirin Co., Ltd.$17.00 BIOYF

-0.05-0.73%

BioSyent Inc.$6.80 MAYNF

Mayne Pharma Group Limited$4.48 RADLY

Raia Drogasil S.A.$4.05 SYMQY

SymBio Pharmaceuticals Limited$1.21 MEDXF

-0.04-3.33%

Medexus Pharmaceuticals Inc.$1.16 NVACF

Nova Cannabis Inc.$0.87

Company Overview

The Greater Cannabis Company, Inc. (OTC:GCAN) closed at $0.37 USD, gaining $0.02 (5.71%) from the previous close of $0.35. The stock is currently mid-range between its 52-week high and low $0.04 and $0.67. With a market capitalization of about $367.92 thousand, The Greater Cannabis Company, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.34). Key stats such as the average daily volume over the past year has been around 4.03 thousand shares, volume is running light vs its 52-week average. Headquartered in Miami, FL, The Greater Cannabis Company, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Porfirio Sánchez-Talavera, the company employs approximately 1 people and listed since September 18, 2018. The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics.

Technical Performance

Average 10-day trading volume of 6.56 thousand shares is slightly above the 3-month average of 5.94 thousand, indicating heightened recent market interest.

Valuation Metrics

The Greater Cannabis Company, Inc. trades at a P/E ratio of 0.61, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -30336.43 indicating negative book value, which may reflect financial stress. The P/FCF stands at -9.04, also below market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Financial & Profitability Overview

Over the trailing twelve months, Greater Cannabis has not generated any revenue. Returns are negative, with ROA at -109.36% and ROE at 28.49%.
On valuation metrics, Greater Cannabis trades at a P/E of 0.61, P/S of 0.00 and P/B of -30336.43. Liquidity is tight, with a current ratio of 0.01 and quick ratio of 0.01. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 10712.79 days.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Greater Cannabis posted revenue of $0.00, down slightly from $0.00 in the prior quarter. Gross profit was - $5.00K (margin 0.00%). Operating income was - $175.36K (margin 0.0%). Net income was- $188.40K (EPS - $0.00).
The company ended the quarter with $166.86K in cash and short-term investments, a total debt of $431.44K, and net debt of $264.58K. Total assets were $172.28K, with equity of - $661.23K. Financials further reflected weakness, with operating cash flow of - $103.17K, free cash flow of - $103.17K, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that The Greater Cannabis Company, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows The Greater Cannabis Company, Inc. trading at a premium to the broader market with a P/E of 0.61.

Frequently Asked Questions

What is the current The Greater Cannabis Company, Inc. (GCAN) stock price?

The Greater Cannabis Company, Inc. (OTC: GCAN) stock price is $0.37 in the last trading session. During the trading session, GCAN stock reached the peak price of $0.38 while $0.35 was the lowest point it dropped to. The percentage change in GCAN stock occurred in the recent session was 5.71% while the dollar amount for the price change in GCAN stock was $0.02.

GCAN's industry and sector of operation?

The OTC listed GCAN is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. The Greater Cannabis Company, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GCAN?

Mr. Aitan Zacharin
Chairman, Pres, Chief Executive Officer, Acting Chief Financial Officer & Treasurer

How GCAN did perform over past 52-week?

GCAN's closing price is 75% higher than its 52-week low of $0.04 where as its distance from 52-week high of $0.67 is -53.33%.

How many employees does GCAN have?

Number of GCAN employees currently stands at 1.

Link for GCAN official website?

Official Website of GCAN is: https://www.gcanrx.com

How do I contact GCAN?

GCAN could be contacted at phone 443 738 4051 and can also be accessed through its website. GCAN operates from 200 South Biscayne Blvd, Miami, FL 33131, United States.

How many shares of GCAN are traded daily?

GCAN stock volume for the day was 200 shares. The average number of GCAN shares traded daily for last 3 months was 4.03K.

What is the market cap of GCAN currently?

The market value of GCAN currently stands at $367.92K with its latest stock price at $0.37 and 994.38K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1
Beta	0.34
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Pharmaceuticals

GCAN Company Profile and Key Details

Greater Cannabis

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics